Michael Schmidt
Equity research analyst · Guggenheim
Earnings calls
1
Nov 4, 2026 – Nov 4, 2026
Stocks asked about
1
Questions
1
Firm rating actions
0
on these stocks, from news
Coverage
Companies whose earnings calls Michael Schmidt asked questions on (from Lician's transcripts).
Questions on earnings calls
- URGN earnings call · UroGen Pharma Ltd.Nov 4, 2026 · 1 question
- 48:44
“Just a question on the UGN 103 transition. With the plan to submit the 12-month durability data for FDA review, do you see this durability update? Changing the label? And then also, how long do you expect there to be an overlap between the transition from SysDuri to UGN 103…”
- 48:44
Quotes are machine transcriptions of the official webcast (Whisper) and may contain errors; the timestamp opens the call at that moment.
Guggenheim rating actions on these stocks
From news headlines Lician stores, each linked to its source. A headline names the firm; it may not name Michael Schmidt. We do not use licensed rating databases.
No rating action by Guggenheim on these stocks in the headlines we store yet.